Strumento inattivo

Altre lingue Tryp Therapeutics Inc. Canadian Securities Exchange

Azioni

Tryptamine Therapeutics Partners with Lucid Health to Advance TRP-8803's Product Registration in Australia	19/06
Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118%	29/05
Tryp Therapeutics Files Amended Financial Statements for the Six Months Ended February 29, 2024	17/05
Tryptamine Therapeutics Limited Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	29/04
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 18-DEC-2023.	18/12
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 20-JUN-2023.	20/06/23

Non ci sono risultati per questa ricerca